Determining Minimal Residual Disease Using ctDNA Deep Sequencing

NCT07660627 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Masaryk Memorial Cancer Institute